Diet, Physical Activity and Glucose Tolerance in Cystic Fibrosis. Exploratory Study.

CompletedOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

November 8, 2021

Study Completion Date

November 8, 2021

Conditions
Cystic Fibrosis
Interventions
OTHER

Questionnaire

"During this consult, several parameters will be measured :~* nutritional and physical activity parameters: Food Frequency Questionnaire (FFQ), International Physical Activity Questionnaire (IPAQ), Three-Factor Eating Questionnaire (TFEQ-R18), impedance test, anthropometric measurements, resting energy expenditure~* demographic and clinical parameters : Family history, date of birth (month and year), sex, genotype, best forced expiratory volume (FEV) (over the 12 months preceding inclusion), bacterial colonization~* patient treatment and biologic parameters: corticosteroid therapy (with dosage, over the 12 months preceding inclusion), antidiabetic treatment (oral or insulin), IV antibiotic treatment, corrective treatments, pancreatic enzymes, OGTT (blood glucose and insulin levels at three times), lipid balance, vitamin dosage."

Trial Locations (1)

69495

Service de médecine interne - CRCM Lyon Adultes, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04249466 - Diet, Physical Activity and Glucose Tolerance in Cystic Fibrosis. Exploratory Study. | Biotech Hunter | Biotech Hunter